gip and glp 1 Indications for GLP-1/GIP RA Summary Sheet Beyond! Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP)
Description
Medicina (Kaunas) 58(10):1382 Yang A, Wu H, Lau ESH, Zhang X, Shi M, Fan B, et al (2022) Glucose-lowering drug use, glycemic outcomes, and severe hypoglycemia: 18-year trends in 09 million adults with diabetes in Hong Kong (20022019)

Pfizer - Partnership (December 2025): Pfizer struck a $2 billion deal with YaoPharma to develop and commercialize a phase 1 small-molecule GLP-1 receptor agonist [1]

According to a clinical research plan updated by the company in early 2024, Lilly will conduct multiple Phase 3 clinical trials for Retatrutide over the next three years, with targeted indications primarily including obesity, chronic kidney disease, and type 2 diabetes

Talk with your doctor or pharmacist if you have questions about what to eat or drink while taking these medications

Weight loss solutions for sleep apnea Lofta collaborates with Accomplish Health to offer weight management solutions that can help you tackle sleep apnea

CHS Reports $70M Q4 Loss : Community Health Systems reported a $70 million loss in Q4 2024
